Final answer:
Patients with rheumatoid arthritis are usually given a combination of an NSAID and methotrexate to help relieve pain, decrease inflammation, and slow the progression of the disease by targeting the autoimmune processes.
Step-by-step explanation:
A newly diagnosed patient with rheumatoid arthritis (RA) is typically prescribed a non-steroidal anti-inflammatory drug (NSAID) and methotrexate to manage their condition. NSAIDs, such as aspirin, are used to relieve pain and decrease inflammation in the affected joints.
Methotrexate is a disease-modifying antirheumatic drug (DMARD) that not only reduces symptoms but also slows the progression of joint damage by targeting the underlying autoimmune processes. It acts to reduce the impact of the autoimmune response, which includes inhibiting the inflammatory response and reducing the number of T lymphocytes, cells that are part of the immune system. This combined treatment approach aims to improve joint function, decrease pain, and ultimately enhance the quality of life for individuals with RA.